Tamoxifen citrate induced sperm shape abnormalities in the in vivo mouse

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 492, Issue 1-2, 2001, Pages 1-6

  Padmalatha Rai, S ^a   Vijayalaxmi, K K ^b  

^a KUVEMPU UNIVERSITY   (India)

^b MANGALORE UNIVERSITY   (India)

Author keywords

Sperm abnormality; Sperm count; Swiss albino mice; Tamoxifen citrate

Indexed keywords

TAMOXIFEN CITRATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; GENOTOXICITY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPERMATOZOON ABNORMALITY; SPERMATOZOON COUNT; STATISTICAL ANALYSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MUTAGENICITY TESTS; MUTAGENS; ORGAN SIZE; SPERM COUNT; SPERMATOZOA; TAMOXIFEN; TESTIS;

EID: 0035978765     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(00)00160-1     Document Type: Article

References (37)

1. Martindale, in: E.J. James, R. Kahlbenparfitt, V. Parsons, S.C. Sweet man (Eds.), The Extra Pharmacopoeia, 29th Edition, The Pharmaceutical Press, London, 1990.
2. Hard G.C., Iatropoulos M.J., Jordan K., Radi L., Kaltenberg O.P., Imondi A.R., Williams G.M. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toreminfene and tamoxifen in female Crl: CD (BR) rats. Cancer Res. 53:1993;4534-4544.
3. Moorthy B., Liehr J., Randerath E., Randerath K. Evidence from 32p-post labeling and use of pentachlorophenol for a novel metabolic activation pathway of diethylstilbestrol and its dimethyl ether in mouse liver: likely alpha-hydroxylation of ethyl group (s) followed by sulfate conjugation. Carcinogenesis. 16:1995;2643-2648.
4. Herbst A., Ulfelder H., Poskanzer D. Adenocarcinoma of vagina, association of maternal stilbestrol therapy with tumor appearance in young woman. N. Engl. J. Med. 284:1971;878-881.
5. Han X., Liehr J.G. Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res. 52:1992;1360-1363.
6. White I.N.H., deMatteis F., Davies A., Smith L.L., Crofton-Sleigh C., Venitt S., Hewer A., Phillips D.H. Genotoxic potential of tamoxifen and analogues in female Fisher F 344/n rats, DBA/2 and C 57BL/6 mice and in human MCL-5 cells. Carcinogenesis. 13:1992;2197-2203.
7. Pathak D.N., Bodell W.J. DNA adducts formation by tamoxifen with rat human liver microsomal activation system. Carcinogenesis. 15:1994;529-532.
8. Potter G.A., McCague R., Jarman M. A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism. Carcinogenesis. 15:1994;439-442.
9. Phillips D.H., Hewer A., White I.N.H., Farmer P.B. Co-chromatography of a tamoxifen epoxide-deoxyguanylic acid adduct with a major DNA adduct formed in the livers of tamoxifen treated rats. Carcinogenesis. 15:1994;793-795.
10. Osborne M.R., Hewer A., Davis W., Strain A.J., Koegh A., Hardcastle-Ian R., Phillips D.H. Idoxifen derivatives are less reactive to DNA than tamoxifen derivatives, both chemically and in human and rats liver cells. Carcinogenesis. 20:1999;293-297.
11. Moorthy B., Sriram P., Randerath E., Randerath K. Effect of cytochrome p450 inducers on tamoxifen genotoxicity in female mice in vivo. Biochem. Pharmacol. 53:1997;663-669.
12. Carmichael P.L., Ugwumadu A.H., Neven P., Hewer A.J., Poon G.K., Phillips D.H. Lack of genetoxicity of tamoxfen in human endometrium. Cancer Res. 56:1996;1475-1479.
13. I.S. Fentiman, M. Caleffi, K. Bkami, M.A. Chaudary, Double blind controlled trial of tamoxifen therapy for mastalgia, Lancet (1986) 1221-1226.
14. Comoglio A., Gibbs A.H., White-Ian N.H., Gant T., Martin E.A., Smith L.L., Gamalero S.R., Dematteis F. Effect of tamoxifen feeding on metabolic activation of tamoxifen by the liver of the Rhesus monkey: dose liver accumulation of inhibitory metabolites protects from tamoxifen-dependent genotoxicity and cancer. Carcinogenisis. 17:1996;1687-1693.
15. Nuwaysir E.F., Daggett D.A., Jordon V.C., Pitot H.C. Phase II enzyme expression in rat liver in response to antiestrogen tamoxifen. Cancer Res. 56:1996;3704-3710.
16. Vancutsem P.M., Lazarus P., Williams G.M. Frequent and specific mutations of rat p53 gene in hepatocarcinoma induced by tamoxifen. Cancer Res. 54:1994;3864-3867.
17. Styles J.A., Davies A., Lim C.K., deMatteis F., Stanley L.A., White I.N.H., Yuan Z.X., Smith L.L. Genotoxicity of tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome-p450S. Carcinogenesis. 15:1994;5-9.
18. K Vijayalaxmi K., Padmalatha Rai S. Studies on the genotoxicity of tamoxifen citrate in mouse bone marrow cells. Mutat. Res. 368:1996;109-114.
19. I.D. Adler, Cytogenetic tests in mammals, in: S. Venitt, J.M. Parry (Eds.), Mutagenicity Testing, A Practical Approach, IRL Press, Oxford, 1984, pp. 275-306.
20. Wyrobek A.J., Gordon L.A., Burkhart J.G., Francis M.W., Kapp R.W., Letz G., Malling H.V., Topham J.C., Whorton M.D. An evaluation of the mouse sperm morphology test and other sperm tests in non-human mammals. Mutat. Res. 115:1983;1-72.
21. Wyrobek A.J., Bruce W.R. Chemical induction of sperm abnormalities in mice. Proc. Natl. Acad. Sci. (USA) Cell Biol. 72:1975;4425-4429.
22. Vega S.G., Guzman P., Garcia L., Espinosa J., deNova C.C. Sperm shape abnormality and urine mutagenicity in mice treated with niclosamide. Mutat. Res. 204:1988;269-276.
23. S. Siegel, Nonparametric Statistics for the Behavioral Sciences, McGraw-Hill, Kogakusha Ltd., Tokyo, 1956, pp. 117-127.
24. Au W.W., Hsu T.C. The genotoxic effects of adriamycin in somatic and germinal cells of mouse. Mutat. Res. 79:1980;351-361.
25. Wyrobek A.J., Gordon L.A., Burkhart J.G., Francis M.W., Kapp R.W., Letz G., Malling H.V., Topham J.C., Whorton M.D. An evaluation of human sperm as indicators of chemically induced alterations of spermatogenic function. Mutat. Res. 115:1983;73-148.
26. Bruce W.R., Furrer R., Wyrobek A.J. Abnormalities in the shape of murine sperm after acute testicular X-irradiation. Mutat. Res. 23:1974;381-386.
27. Topham J.C. The detection of carcinogen induced sperm head abnormalities in mice. Mutat. Res. 69:1980;149-155.
28. Topham J.C. Chemically induced transmissible abnormalities in sperm head shape. Mutat. Res. 70:1980;109-114.
29. Krzanoswska H. Inheritance of sperm head abnormalities in mice and the role of Y chromosome. Genet. Res. 28:1976;189-198.
30. Styrna J., Imai H.T., Moriwaki K. An increased level of sperm abnormalities in mice with a partial deletion of the Y chromosome. Genet. Rev. Camb. 57:1991;195-199.
31. Osborne M.R., Hard castle I.R., Phillips D.H. Minor products of reaction of DNA with alpha-acetoxytamoxifen. Carcinogenesis. 18:1997;539-543.
32. Shibutani S., Suzuki N., Terashima I., Sugarman S.M., Grollman A.P., Pearl M.L. Tamoxifen-DNA adducts detected in the endometrium of woman treated with tamoxifen. Chem. Res. Toxicol. 12:1999;646-653.
33. Liehr J.G., Avitts T.A., Randerath E., Randerath K. Estrogen induced endogenous DNA adduction, possible mechanism of hormonal cancer. Proc. Natl. Acad. Sci. USA. 83:1986;5301-5305.
34. Lim C.K., Yuan Z., Lamb J.H., White I.N.H., deMatteis F., Smith L.L. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes. Carcinogenisis. 15:1994;589-593.
35. Lyman S.D., Jordan V.C. Metabolism of tamoxifen and its utertotrophic activity. Biochem. Pharmacol. 34:1985;2787-2794.
36. Evans H.J., Neary G.J., Williamson F.S. The relative biological efficiency off single doses of fast neutrons and gamma rays on Vicia faba roots and the effect of oxygen II. Chromosomal damage, the production of micronuclei. Int. J. Radiat. Biol. 1:1959;216-229.
37. A.J. Wyrobek, Sperm assays as indicators of chemically induced germ cell damage in man, in: A.J. Heddle (Ed.), Mutagenicity, New Horizons in Genetic Toxicolgy, Academic Press, New York, 1982, pp. 337-349.